Aetna (CVS Health) Coverage Criteria for Tagrisso (Osimertinib) in Pennsylvania: What Counts as "Medically Necessary"?
Answer Box: Getting Tagrisso (Osimertinib) Covered by Aetna (CVS Health) in Pennsylvania
Aetna (CVS Health) requires prior authorization for Tagrisso with documented EGFR mutation testing (exon 19 deletion or L858R) and FDA-approved indication. Submit through CVS Caremark Specialty (1-866-814-5506) with complete clinical documentation. If denied, you have 180 days for